The Pioneer and Daiichi Sankyo Golden Ticket Accelerator/Incubator The Golden Ticket programme is aimed at early-stage biotech companies focused on novel drug targets and transformational medicines, with robust research plans and potential for successful research development. Find out more Deadline: 30 May 2025
